Von Willebrand Factor Type C Domain-containing Proteins Regulate Bone Morphogenetic Protein Signaling Through Different Recognition Mechanisms.
From: Department of Physiological Chemistry II, Biocenter, University of Wuerzburg, Am Hubland, 97074 Wuerzburg, Germany. zhang@biozentrum.uni-wuerzburg.de
The Journal of biological chemistry
- Publish Date: Jul 2007
- ISSN: 0021-9258
- Volume: 282
- Issue: 27
- Pages: 20002-14
- Medium: Print
- Language: English
- Citation (JAMA): Zhang Jin-Li, Huang Yi, Qiu Li-Yan, et al. Von Willebrand Factor Type C Domain-containing Proteins Regulate Bone Morphogenetic Protein Signaling Through Different Recognition Mechanisms.. J. Biol. Chem. Jul 2007;282:20002-14
Abstract
Bone morphogenetic protein (BMP) function is regulated in the extracellular space by many modulator proteins, including those containing a von Willebrand factor type C (VWC) domain. The function of the VWC domain-containing proteins in development and diseases has been extensively studied. The structural basis, however, for the mechanism by which BMP is regulated by these proteins is still poorly understood. By analyzing chordin, CHL2 (chordin-like 2), and CV2 (crossveinless 2) as well as their individual VWC domains, we show that the VWC domain is a versatile binding module that in its multiple forms and environments can expose a variety of binding specificities. Three of four, two of three, and one of five VWCs from chordin, CHL2, and CV2, respectively, can bind BMPs. Using an array of BMP-2 mutant proteins, it can be demonstrated that the binding-competent VWC domains all use a specific subset of BMP-2 binding determinants that overlap with the binding site for the type II receptors (knuckle epitope) or for the type I receptors (wrist epitope). This explains the competition between modulator proteins and receptors for BMP binding and therefore the inhibition of BMP signaling. A subset of VWC domains from CHL2 binds to the Tsg (twisted gastrulation) protein similar to chordin. A stable ternary complex consisting of BMP-2, CHL2, and Tsg can be formed, thus making CHL2 a more efficient BMP-2 inhibitor. The VWCs of CV2, however, do not interact with Tsg. The present results show that chordin, CHL2, and CV2 regulate BMP-2 signaling by different recognition mechanisms.
Mesh Headings (Keywords): Animals, Bone Morphogenetic Proteins, Carrier Proteins, Glycoproteins, Intercellular Signaling Peptides and Proteins, Mice, Protein Binding, Protein Structure, Tertiary, Proteins, Signal Transduction, Transforming Growth Factor beta, Zebrafish, von Willebrand Factor
Check for Full Text / PubMed Unique Identifier (PMID): 17483092
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.